登录新浪财经APP 搜索【信披】查看更多考评等级 （一）定价政策和定价依据 公司及子公司与关联方开展关联交易，将遵循诚实信用、等价有偿、公平自愿、合理公允的基本原则， 按实际交易时的市场价格确定成交价格；如任何第三方的购销条件优于上述关联方所给予的条件，公司 及子公司有权向第三方采购或销售。 公司将严格遵守《蓝帆医疗股份有限公司章程》与《关联交易决策制度》的相关规定，以确保关联交易 的公允性。 （二）关联交易协议签署情况 公司及子公司与关联交易各方将根据生产经营的实际需求，在本次日常关联交易预计额度范围内签订合 同并进行交易。 四、关联交易目的和对上市公司的影响 （一）关联交易的原因、目的、必要性及持续性 1、公司及子公司拟向朗晖石化及其子公司采购原材料 增塑剂、糊树脂是公司健康防护手套的主要生产原料，公司的关联方朗晖石化协同下属子公司为全国最 大、供应最稳定的增塑剂产品制造商，市场份额约占全国三分之一，同时，朗晖石化为全国头部的糊树 脂生产企业，可以提供稳定、充足且高质量的增塑剂和糊树脂产品。随着行业竞争加剧，增塑剂市场逐 渐形成了显著的区域化格局。公司的健康防护手套工厂与朗晖石化的生产工厂均位于山东，相较 ...

Group 1 - The company plans to adjust its business operations in the U.S. market to ensure long-term participation, reduce operational risks, and protect the interests of the company and its investors [2][3][16] - The transaction involves the establishment of joint ventures with the controlling shareholder, Canadian Solar Inc. (CSIQ), which will not constitute a major asset restructuring [2][3][4] - The joint ventures will focus on solar photovoltaic and energy storage businesses in the U.S., with CSI holding 24.9% and CSIQ holding 75.1% of the shares [4][16] Group 2 - The U.S. is currently the second-largest photovoltaic market globally, with a mature electricity market mechanism and a rapidly growing energy storage business [3][16] - The company will transfer certain overseas manufacturing assets to CSIQ, allowing it to receive a one-time equity transfer payment while retaining a 24.9% stake in future U.S. business profits [4][16][19] - The joint ventures will begin operations by leasing some of CSI's overseas assets, with plans for future investments or acquisitions [4][16] Group 3 - The financial data for the overseas battery factory GNCM is estimated at RMB 36.68 million, while the overseas energy storage factory SSTH is valued at RMB 377.78 million, and the overseas photovoltaic slicing factory THX1 is valued at RMB 54.86 million [9][10] - The total estimated value for the equity transfer of 75.1% is approximately RMB 352.47 million [9][10] Group 4 - The company has received approval from its board of directors for the transaction, which will be submitted for shareholder approval [14][15] - The independent directors have unanimously agreed that the transaction complies with policy requirements and protects the interests of minority shareholders [14][15][34] Group 5 - The company expects to engage in daily related transactions amounting to no more than RMB 55.27 billion in 2026, which will be conducted on a voluntary and fair basis [26][33] - The company has established a fair pricing mechanism for its related transactions, ensuring that they do not harm the interests of the company and its shareholders [32][33]